Simon Quick Advisors LLC Has $3.34 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Simon Quick Advisors LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 25.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,381 shares of the healthcare conglomerate's stock after purchasing an additional 1,280 shares during the quarter. Simon Quick Advisors LLC's holdings in UnitedHealth Group were worth $3,342,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Geode Capital Management LLC increased its stake in UnitedHealth Group by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock valued at $10,068,869,000 after acquiring an additional 319,515 shares during the period. Capital International Investors increased its position in shares of UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock valued at $7,899,905,000 after purchasing an additional 906,365 shares during the period. Norges Bank bought a new position in UnitedHealth Group in the fourth quarter worth $6,375,744,000. Northern Trust Corp increased its holdings in UnitedHealth Group by 12.5% in the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock valued at $4,807,527,000 after buying an additional 1,058,488 shares during the period. Finally, Franklin Resources Inc. boosted its position in shares of UnitedHealth Group by 10.7% during the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after acquiring an additional 861,854 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 1.7%

UNH traded down $5.31 during midday trading on Friday, reaching $313.19. 9,413,889 shares of the company were exchanged, compared to its average volume of 7,161,205. The stock has a market capitalization of $284.11 billion, a P/E ratio of 20.20, a PEG ratio of 1.37 and a beta of 0.45. The stock's 50-day simple moving average is $391.47 and its 200 day simple moving average is $476.22. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period last year, the firm earned $6.91 EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.82%. The ex-dividend date of this dividend is Monday, June 16th. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio is 37.02%.

Analyst Ratings Changes

UNH has been the subject of a number of analyst reports. Raymond James cut shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. TD Cowen cut UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target on the stock. in a research report on Monday, May 19th. Oppenheimer reduced their target price on shares of UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating on the stock in a research note on Wednesday, May 14th. Wall Street Zen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Finally, Baird R W cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday. One research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $426.52.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,533 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Kristen Gil acquired 3,700 shares of the company's stock in a transaction on Thursday, May 15th. The stock was acquired at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the purchase, the director now directly owns 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased a total of 109,408 shares of company stock valued at $31,607,768 over the last ninety days. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.